Molecular

4D Molecular Therapeutics Reports Positive Interim Data From Phase 2b Trial For Wet AMD

(RTTNews) - 4D Molecular Therapeutics (FDMT) announced positive initial interim 52-week data from the Phase 2b Population Extension cohort of…

4 days ago

4D Molecular Therapeutics Reports Positive Interim Data From Phase 2b Trial For Wet AMD

(RTTNews) - 4D Molecular Therapeutics (FDMT) announced positive initial interim 52-week data from the Phase 2b Population Extension cohort of…

4 days ago